Delivery Order SPE2DB20D3303-SPE2DB24FA3AJ
Award Date
9/12/24
Potential Completion Date
9/13/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,318.43 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of July 18, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $17,195.02 firm fixed price delivery order is for the supply of 4,565,751,041 units of Candesartan Cilexetil 16 mg tablets in 90-count packages. The contract does not have a set-aside designation and has an ultimate completion date of September 11, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, has been awarded...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,347.24 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,191.88 Firm Fixed Price Delivery Order provides candesartan cilexetil 16 mg tablets in 90-count packages. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $33,385.99 fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of June 6, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,840.66 Firm Fixed Price delivery order contract is for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of July 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of candesartan cilexetil 16 mg tablets. The contract has a firm fixed-price delivery order type and a ceiling value of $3,379.06, with a completion date of July 19, 2024. This contract is not associated with a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded numerous federal...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,854.92, is a delivery order for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,826,834 units of the prescription drug Candesartan Cilexetil 16 mg tablets. The firm-fixed-price delivery order contract has a ceiling value of $15,702.81 and an ultimate completion date of September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which does not have a set-aside designation. This contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,575.64, is for the delivery of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...